Heavy menstrual bleeding matters because of its effect on health and daily life, not just a measured volume. Flooding, frequent changes of protection, night-time disruption or avoiding normal activities are useful details to report.
Describe the impact
Record how often you change protection, whether you pass clots, how many days bleeding lasts and whether you need two products together. Mention tiredness, breathlessness, dizziness or palpitations, which may need assessment for anaemia or other causes. You do not have to tolerate heavy bleeding simply because it has become familiar.
Causes and tests vary
Fibroids, polyps, adenomyosis, hormonal changes and other conditions may be considered. Medicines and a history of bleeding problems can also matter. The clinician may recommend blood tests, ultrasound or examination of the uterine cavity depending on the pattern and associated symptoms.
Treatment should fit your priorities
Discuss whether you want contraception, are trying to conceive or hope for a future pregnancy. These goals can affect which medical or procedural options are appropriate. Ask how quickly a treatment should help, which side effects matter and what happens if bleeding remains troublesome.
Make a safety and follow-up plan
Seek urgent care for very heavy bleeding with weakness, faintness, chest discomfort or significant breathlessness. At a routine review, ask whether iron levels or haemoglobin need follow-up and whether the suspected cause has been adequately assessed. Keep a record of response to treatment. Improvement should mean a better quality of life as well as a change in a test result.
Sources & further reading
International resources provide background information. Your clinician can explain the approach, screening schedule and requirements relevant to you in India.
General information cannot diagnose a condition or replace personal medical advice. For severe or rapidly worsening symptoms, seek urgent medical care.
The archive date organises this collection. This guide was first published on 29 October 2026.
